Randomized, double‐blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy

Overview of attention for article published in Hepatology, February 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 6 news outlets
blogs: 1 blog
twitter: 7 X users
patent: 14 patents

facebook: 1 Facebook page
wikipedia: 1 Wikipedia page
guideline: 4 clinical guideline sources

Readers on

mendeley: 129 Mendeley

So far, Altmetric has seen 14 patents that reference this research output.

L-ornithine phenyl acetate and methods of making thereof

Grant US-12516015-B2

United States of America

06 Jan 2026

Methods of assessing hepatic encephalopathy

Grant US-12396675-B2

United States of America

26 Aug 2025

COMBINATION OF TLR4 ANTAGONIST, ORNITHINE AND PHENYLACETATE OR PHENYLBUTYRATE

Application WO-2024261477-A1

World Intellectual Property Organisation (WIPO)

26 Dec 2024

FORMULATIONS OF L-ORNITHINE PHENYLACETATE

Application EP-4205735-A1

European Patent Office

05 Jul 2023

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 10 additional patents.